Schierjia (301371): 24Q1 revenue +9.7% YoY, cosmetics business continues to gain strength to drive growth
Incident Overview. The company released its 2023 annual report and 2024 quarterly report on April 26. In 2023, it achieved operating income of 1.934 billion yuan, +9.29% year-on-year; realized net profit of 749 million yuan to mother
Bettany (300957): Revenue growth in 23 years, performance under pressure for 24 years, looking forward to an improvement in business quality
Revenue and net profit attributable to mother in '23 were +10%, -28% YoY, 24Q1 +27%, +12%. Bettany published the 2023 Annual Report and the 2024 Quarterly Report. The company achieved operating income in 202355
Schierjia (301371): Increasing the proportion of online direct sales, increasing R&D and consolidating long-term competitiveness
Incident: The company released its 2023 annual report and 2024 quarterly report: 2023 revenue of 1,934 million yuan (+9.3% YoY), net profit to mother of 749 million yuan (-11.6% YoY), deducted from non-return
Guolian Securities released a research report on April 27 stating that it gave Shiljia (301371.SZ) an increase in holdings rating. The main reasons for the rating include: 1) the company published its 2023 annual report and 2024 quarterly report; 2) stead
Guolian Securities released a research report on April 27 stating that it gave Shiljia (301371.SZ) an increase in holdings rating. The main reasons for the rating include: 1) the company published its 2023 annual report and 2024 quarterly report; 2) steady revenue growth and an increase in the share of direct online sales; 3) steady equipment, strong cosmetics, and parallel channel breadth and depth. (Mainichi Keizai Shimbun)
Express News | Kangenbei's innovative traditional Chinese medicine yellow holly flower flavonoid oral patch received a reward of 10 million yuan from the government
Express News | The concept of computing power continues to ferment, and many leading telecommunications companies have received intensive research from institutions